Erratum to “Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years” [Multiple Sclerosis and Related Disorders, Volume 67, November 2022, 104187] (Multiple Sclerosis and Related Disorders (2022) 67, (S2211034822006927), (10.1016/j.msard.2022.104187))

The publisher regrets that in the originally published version of this article, two supplementary tables that were provided with the accepted manuscript were inadvertently omitted from the published supplementary material. The missing supplementary tables are now included with this Erratum and are listed below: Supplement Table 1. Supplement Table 1. Demographic and clinical characteristics at baseline and over the follow-up in 176 PwMS, according to the confirmed disability progression status at the 10-year follow-up. [Table Presented] Supplement Table 2. Supplement Table 2. T2 lesion-based baseline and follow-up characteristics in PwMS, according to the baseline EDSS score. [Table Presented] The volumes are presented in milliliters. The baseline p values were derived using one-way ANOVA, while the follow-up changes p values were calculated using analysis of covariance corrected for age, sex and treatment change over the follow-up. The Benjamini-Hochberg correction was used to minimize the false discovery rate and p-values <0.05 were considered significant. In bold are presented significant p-values <0.05. The omission of these supplementary tables was an inadvertent production error and does not affect the results, interpretation, or conclusions of the article. The supplementary tables should be considered part of the original article and are now provided to ensure that the published record is complete. The authors and publisher apologize for any inconvenience caused by this omission. The publisher would like to apologise for any inconvenience caused.